- Home
- / Shield Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Shield Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$11.8 M
Revenue
£11.9 M
FY, 2018
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2014 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|
| Revenue | 244.0K | 304.0K | 637.0K | 11.9M |
| Cost of goods sold | 100.0K | 155.0K | 311.0K | |
| Gross profit | 204.0K | 482.0K | 11.6M | |
| Gross profit margin, % | 67.1% | 75.7% | 97.4% | |
| Depreciation and amortization | 5.0K | 6.0K | 6.0K | 5.0K |
| EBIT | (3.4M) | (12.5M) | (21.0M) | (5.2M) |
| EBIT margin, % | -1389.8% | -4098.7% | -3289.0% | -43.5% |
| Interest income | 58.0K | 15.0K | 20.0K | |
| Interest expense | 1.7M | 14.0K | 17.0K | 35.0K |
| Pre tax profit | (13.4M) | (15.6M) | (21.0M) | (5.2M) |
| Income tax expense | (587.0K) | (1.4M) | (3.4M) | |
| Net Income | (13.4M) | (15.0M) | (19.6M) | (1.8M) |